Bradley Wubbenhorst Selected Research

Bradley Wubbenhorst Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 01/2012
11	Melanoma (Melanoma, Malignant) 12/2023 - 12/2010
7	Atopic Dermatitis (Atopic Eczema) 12/2022 - 08/2014
4	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 07/2016
2	Neoplasm Metastasis (Metastasis) 11/2017 - 11/2014
1	Testicular Germ Cell Tumor 05/2023
1	Hypersensitivity (Allergy) 01/2023
1	Skin Diseases (Skin Disease) 12/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Chronic Disease (Chronic Diseases) 11/2019
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2018
1	Kidney Neoplasms (Kidney Cancer) 06/2018
1	Ovarian Epithelial Carcinoma 07/2016
1	Brain Neoplasms (Brain Tumor) 11/2014

Drug/Important Bio-Agent (IBA)

5	Filaggrin ProteinsIBA 12/2022 - 08/2014
3	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2017
3	PlatinumIBA 01/2021 - 07/2016
2	Proteins (Proteins, Gene)FDA Link 05/2023 - 11/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 07/2016
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2016 - 01/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2013 - 12/2010
2	dabrafenibIBA 09/2013 - 09/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	CytokinesIBA 01/2022
1	Thymic Stromal LymphopoietinIBA 12/2019
1	Checkpoint Kinase 2IBA 04/2019
1	PerforinIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	alpha-2'-deoxythioguanosineIBA 10/2018
1	NucleosidesIBA 10/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2018
1	Urea (Carbamide)FDA LinkGeneric 06/2018
1	ArginaseIBA 06/2018
1	EnzymesIBA 06/2018
1	GlycogenIBA 06/2018
1	LipidsIBA 06/2018
1	PolyaminesIBA 06/2018
1	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 06/2018
1	pembrolizumabIBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Sorafenib (BAY 43-9006)FDA Link 01/2016
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2015
1	Messenger RNA (mRNA)IBA 11/2014
1	omipalisibIBA 09/2013
1	trametinibIBA 09/2013
1	Dacarbazine (DIC)FDA LinkGeneric 09/2013
1	Proto-Oncogene Proteins B-rafIBA 09/2013
1	Proteoglycans (Proteoglycan)IBA 01/2012
1	Versicans (Versican)IBA 01/2012
1	Glycoproteins (Glycoprotein)IBA 01/2012
1	teleocalcinIBA 01/2012
1	Proto-Oncogene Proteins A-rafIBA 12/2010
1	Protein Isoforms (Isoforms)IBA 12/2010

Therapy/Procedure

7	Therapeutics 12/2023 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2017 - 07/2016
1	Aftercare (After-Treatment) 01/2017
1	Ligation 09/2013